Newsstand Menu

CSHL receives Nanomedicine Center grant

Print Friendly, PDF & Email

Cold Spring Harbor, NY — The National Institutes of Health has awarded Cold Spring Harbor Laboratory, Caltech, Emory University, Georgia Institute of Technology, The German Cancer Research Center, the Medical College of Georgia, MIT, and New York University Medical Center a five-year, $10 million grant to establish a Nanomedicine Center for Nucleoprotein Machines. The center will initially focus on understanding the molecular machines that enable cells to detect and repair damaged DNA. Defects in the repair of damaged DNA cause or contribute to many human diseases, including cancer. Professor David Spector will lead Cold Spring Harbor Laboratory’s contributions to the center’s research, which will involve multidisciplinary scientific teams comprising biologists, physicians, mathematicians, biomolecular engineers, and computer scientists. The Nanomedicine Center for Nucleoprotein Machines is a key part of the NIH’s goal to explore the potential uses of nanotechnology in medicine.

Written by: Communications Department | publicaffairs@cshl.edu | 516-367-8455

Stay informed

Sign up for our newsletter to get the latest discoveries, upcoming events, videos, podcasts, and a news roundup delivered straight to your inbox every month.

  Newsletter Signup

About Cold Spring Harbor Laboratory

Founded in 1890, Cold Spring Harbor Laboratory has shaped contemporary biomedical research and education with programs in cancer, neuroscience, plant biology and quantitative biology. Home to eight Nobel Prize winners, the private, not-for-profit Laboratory employs 1,000 people including 600 scientists, students and technicians. The Meetings & Courses Program annually hosts more than 12,000 scientists. The Laboratory’s education arm also includes an academic publishing house, a graduate school and the DNA Learning Center with programs for middle, high school, and undergraduate students and teachers. For more information, visit www.cshl.edu